Celldex Therapeutics, Inc. - Company & Market Research Reports

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

From
From
From
From
From
From
From
From
Brain Hemorrhage - Pipeline Insight, 2018 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Drug Pipelines
  • 886 Pages
From
From
Loading Indicator
adroll